TOI
Oncology Institute Inc
NASDAQ: TOI · HEALTHCARE · MEDICAL CARE FACILITIES
$4.05
+4.92% today
Updated 2026-05-01
Market cap
$366.69M
P/E ratio
—
P/S ratio
0.73x
EPS (TTM)
$-0.54
Dividend yield
—
52W range
$2 – $5
Volume
1.8M
Oncology Institute Inc (TOI) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.05
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$13.17
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.3B | $0.4B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -12.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.